Skip to main content
OpenTrials
Completed

NCT Number: NCT03811717

Fasting and Exercise-induced Changes in Human Skeletal Muscle

This study examines the impact of increasing energetic stress during an 8-hour fast on metabolic pathways in human skeletal muscle. Specifically, participants will undergo two 8-hour fasting sessions in a randomized crossover fashion, with the addition of low-intensity arm exercise in one of the sessions. Changes in metabolic pathways will be examined in resting (leg) muscle before, during, and after the fast.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

School of Kinesiology and Health Studies

Kingston, Ontario, K7L3N6, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • recreationally active (no more than 3 hours of weekly physical activity)
  • not currently involved in a systematic training program
  • body mass index < 30 kg/m2

Exclusion criteria

  • presence of cardiometabolic disease
  • taking regular oral medication
  • current smoker

Treatment and study plan

FAST+EX

Other

Participants will perform 2-hours of low-intensity arm exercise (8 x 15 min bouts of arm ergometer exercise separated by 10 min of rest) during an 8-hour fast.

FAST

Other

Participants will complete an 8-hour fast.

Primary outcomes

  1. Peroxisome proliferator activated receptor gamma co-activator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA) expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    PGC-1α gene expression (indirect indicator of PGC-1α activity)

Secondary outcomes

  1. Catecholamine concentrations

    Time frame: 15 min before fast; after exercise; after 4 and 8 hours of fasting

    Epinephrine and norepinephrine concentrations in plasma samples

  2. Glucose and insulin concentrations

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    Glucose and insulin concentrations in plasma samples

  3. total and phosphorylated AMP activated protein kinase (AMPK)

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    active AMPK relative to total AMPK protein content

  4. total and phosphorylated SIRT-1

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    active SIRT-1 relative to total SIRT1 protein content

  5. total and phosphorylated mammalian target of rapamycin (mTOR)

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    active mTOR relative to total mTOR protein content

  6. total and phosphorylated Akt/Protein Kinase B

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    active Akt relative to total Akt protein content

  7. total and phosphorylated acetyl coenzyme A carboxylase (ACC)

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    active ACC relative to total ACC protein

  8. total and phosphorylated p38 mitogen activated protein kinase (MAPK)

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    active p38 MAPK relative to total p38 MAPK protein

  9. phosphorylated protein kinase A (PKA) substrates

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    phosphorylated PKA substrates (indirect measure of PKA activity)

  10. acetylated p53

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    p53 acetylation status (indirect measure of SIRT-1 deacetylase activity)

  11. Sirtuin 1 (SIRT1) mRNA expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    gene expression of the deacetylase enzyme SIRT1

  12. Sirtuin 3 (SIRT3) mRNA expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    gene expression of the deacetylase enzyme SIRT3

  13. Pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) mRNA expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    gene expression of the PGC-1α target PDK4

  14. p53 mRNA expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    gene expression of the tumour suppressor protein p53

  15. Leucine rich pentatricopeptide repeat containing protein (LRP130) mRNA expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    gene expression of RNA-binding protein LRP130

  16. General control non-repressible 5 (GCN5) mRNA expression

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    gene expression of the acetyltransferase GCN5

  17. PGC-1α protein content

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    Protein content of the transcriptional co-activator PGC-1α

  18. Cytochrome C oxidase subunit 4 (COX-IV) protein content

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    Protein content of the mitochondrial enzyme COX subunit 4

  19. Intramuscular glycogen content

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    Muscle glycogen content

  20. Intramuscular triglyceride (IMTG) content

    Time frame: 15 min before fast; after 4 and 8 hours of fasting

    Muscle IMTG content

Sponsors and collaborators

Lead sponsor

Queen's University

Other

Collaborators

  • University of Waterloo

Registry information

Official study title

Impact of Exercise-induced Energetic Stress During an 8-hour Fast on Metabolic Regulation in Resting Human Skeletal Muscle

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jan 22, 2019
Registry last updated
May 30, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.